Biotech Drug Knockoffs Bring Paltry Savings

Price increases of brand-name biotech drugs are diminishing expected savings from rival versions, called biosimilars, adding to pressure on overall health costs.

from WSJ.com: Lifestyle http://ift.tt/1T1vwsx
via LIFESTYLE